Search Within

Li-Zhen He

Formats
  1. Meeting Abstract (14)
  2. Journal Article (8)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (1)
  2. Melanoma and Immunotherapeutics Service (1)
  3. Solid Tumor Oncology Division (1)
People
  1. Pier Pandolfi Derinaldis (23)
  2. Raymond Warrell (10)
  3. Eduardo Rego (7)
  4. Zhu-Gang Wang (6)
  5. Victoria Richon (5)
  6. Paul Marks (3)

More People

Years
  1. 2001 (3)
  2. 2000 (4)
  3. 1999 (3)
  4. 1998 (8)
  5. 1997 (5)
Publications
  1. Blood (13)
  2. Proceedings of the National Academy of Sciences of the United States of America (2)
  3. Anticancer Research (1)
  4. JNCI: Journal of the National Cancer Institute (1)
  5. Journal of Cellular Physiology (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. National Academy of Sciences (2)
  3. Nature Publishing Group (2)
  4. American Society for Clinical Investigation (1)
  5. Cell Press (1)
  6. International Institute of Anticancer Research (1)

More Publishers

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of transcriptional repression and histone deacetylation in APL pathogenesis: A rationale for transcription therapy
    Meeting Abstract

    He, L. Z.; Guidez, F.; Warrell, R. P.; Zelent, A.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Loss of PML function enhances the frequency and onset of APL in PML-RAR alpha transgenic mice
    Meeting Abstract

    Wang, Z. G.; Rego, E.; Peruzzi, D.; He, L. Z.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Role of RAR alpha-PLZF in the pathogenesis of acute promyelocytic leukemia
    Meeting Abstract

    He, L. Z.; Ivins, S.; Zelent, A.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Transcription therapy for cancer: Effects of histone deacetylase (HDAC) inhibitors on proliferation, apoptosis and differentiation of leukemic cell lines
    Meeting Abstract

    He, L. Z.; Tolentino, T.; Warrell, R. P.; Zelent, A.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Therapeutic trials with arsenic trioxide (As(2)O(3)) and retinoic acid in PML-RAR alpha transgenic mice as models of APL
    Meeting Abstract

    Rego, E.; He, L. Z.; Wang, Z. G.; Peruzzi, D.; Warrell, R. P.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Targeted transcription therapy of acute promyelocytic leukemia using an inhibitor of histone deacetylase
    Meeting Abstract

    Warrell, R. P. Jr; He, L. Z.; Richon, V.; Calleja, E.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL
    Journal Article

    He, L. Z.; Guidez, F.; Tribioli, C.; Peruzzi, D.; Ruthardt, M.; Zelent, A.; Pandolfi, P. P.
    Nature Genetics (1998)

    Fulltext@MSK | Save
  • Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
    Journal Article

    Warrell, R. P. Jr; He, L. Z.; Richon, V.; Calleja, E.; Pandolfi, P. P.
    JNCI: Journal of the National Cancer Institute (1998)

    Fulltext@MSK | Save
  • Clinical trials with retinoic acid, IFN, As(2)O(3) and melarsoprol in transgenic models of APL
    Meeting Abstract

    He, L. Z.; Peruzzi, D.; Delva, L.; Wang, Z. G.; Warrell, R. P. Jr; Pandolfi, P. P.
    Anticancer Research (1997)

    Fulltext@MSK | Save
  • Therapeutic trials with retinoic acid and arsenic trioxide (AsO(3)) in PML-RARα and PLZF-RARα transgenic mice as models of APL
    Meeting Abstract

    He, L. Z.; Peruzzi, D.; Tribioli, C.; Warrell, R. P. Jr; Pandolfi, P. P.
    Blood (1997)

    Fulltext@MSK | Save